ABBV CIK: 1551152

AbbVie Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
38.8
FY22:
40.6
FY23:
33.9
FY24:
39.4
FY25:
43.0
(positive)
Change from FY21 to FY25
billions USD
FY21:
17.9
FY22:
18.1
FY23:
12.8
FY24:
9.14
FY25:
15.1
(positive)
Change from FY21 to FY23
billions USD
FY21:
24.0
FY22:
24.3
FY23:
17.3
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
13.0
FY22:
13.5
FY23:
6.25
FY24:
3.72
FY25:
6.60
(positive)
Change from FY21 to FY25
billions USD
FY21:
11.5
FY22:
11.8
FY23:
4.86
FY24:
4.28
FY25:
4.23

All amounts in billions USD Data sources:SEC EDGARTwelve Data